Jiawei Shu

608 total citations
22 papers, 466 citations indexed

About

Jiawei Shu is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jiawei Shu has authored 22 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Jiawei Shu's work include Spinal Cord Injury Research (9 papers), Spine and Intervertebral Disc Pathology (9 papers) and Nerve injury and regeneration (6 papers). Jiawei Shu is often cited by papers focused on Spinal Cord Injury Research (9 papers), Spine and Intervertebral Disc Pathology (9 papers) and Nerve injury and regeneration (6 papers). Jiawei Shu collaborates with scholars based in China, United Kingdom and New Zealand. Jiawei Shu's co-authors include Fangcai Li, Chengzhen Liang, Kaishun Xia, Chenggui Wang, Xianpeng Huang, Qixin Chen, Liwei Ying, Jingkai Wang, Chao Yu and Xiaopeng Zhou and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Small.

In The Last Decade

Jiawei Shu

21 papers receiving 463 citations

Peers

Jiawei Shu

PFM

CMN

SURGE

Biao Yang China

Jin Young Hong South Korea

Hari Prasad Joshi South Korea

Shiqing Feng China

Yuang Zhang China

Changchun Zhang China

Jana Dubišová Czechia

Yunqiang Xu China

Monika Barczewska Poland

Biao Yang China

Jiawei Shu

199 ×0.9

PFM

132 ×0.8

CMN

121 ×1.0

90 ×0.9

SURGE

63 ×0.8

Citations per year, relative to Jiawei Shu Jiawei Shu (= 1×) peers Biao Yang

Countries citing papers authored by Jiawei Shu

Since Specialization

Citations

This map shows the geographic impact of Jiawei Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiawei Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiawei Shu more than expected).

Fields of papers citing papers by Jiawei Shu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiawei Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiawei Shu. The network helps show where Jiawei Shu may publish in the future.

Co-authorship network of co-authors of Jiawei Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiawei Shu. A scholar is included among the top collaborators of Jiawei Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiawei Shu. Jiawei Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yuang, Chengzhen Liang, Haibin Xu, et al.. (2024). Dedifferentiation-like reprogramming of degenerative nucleus pulposus cells into notochordal-like cells by defined factors. Molecular Therapy. 32(8). 2563–2583. 1 indexed citations

Shu, Jiawei, Chenggui Wang, Yiqing Tao, et al.. (2023). Thermosensitive hydrogel‐based GPR124 delivery strategy for rebuilding blood‐spinal cord barrier. Bioengineering & Translational Medicine. 8(5). e10561–e10561. 6 indexed citations

Zhang, Yuang, Xianpeng Huang, Chao Yu, et al.. (2023). Metabolic Glycoengineering: A Promising Strategy to Remodel Microenvironments for Regenerative Therapy. Stem Cells International. 2023. 1–14. 3 indexed citations

Wang, Rui, Jiangjie Chen, Biao Yang, et al.. (2023). Controlled extracellular vesicles release from aminoguanidine nanoparticle-loaded polylysine hydrogel for synergistic treatment of spinal cord injury. Journal of Controlled Release. 363. 27–42. 28 indexed citations

Xu, Haibin, Yuang Zhang, Yujie Zhang, et al.. (2023). A novel rat model of annulus fibrosus injury for intervertebral disc degeneration. The Spine Journal. 24(2). 373–386. 4 indexed citations

Cheng, Feng, Chenggui Wang, Biao Yang, et al.. (2022). Partial reprogramming strategy for intervertebral disc rejuvenation by activating energy switch. Aging Cell. 21(4). e13577–e13577. 29 indexed citations

Shi, Kesi, Chengzhen Liang, Xianpeng Huang, et al.. (2022). Collagen Niches Affect Direct Transcriptional Conversion toward Human Nucleus Pulposus Cells via Actomyosin Contractility. Advanced Healthcare Materials. 12(1). e2201824–e2201824.

Xia, Kaishun, Dongdong Li, Chenggui Wang, et al.. (2022). An esterase-responsive ibuprofen nano-micelle pre-modified embryo derived nucleus pulposus progenitor cells promote the regeneration of intervertebral disc degeneration. Bioactive Materials. 21. 69–85. 26 indexed citations

Ying, Liwei, Chengzhen Liang, Yujie Zhang, et al.. (2022). Enhancement of nucleus pulposus repair by glycoengineered adipose-derived mesenchymal cells. Biomaterials. 283. 121463–121463. 18 indexed citations

10.

Yang, Biao, Chengzhen Liang, Di Chen, et al.. (2021). A conductive supramolecular hydrogel creates ideal endogenous niches to promote spinal cord injury repair. Bioactive Materials. 15. 103–119. 80 indexed citations

11.

Yu, Chao, Dongdong Li, Chenggui Wang, et al.. (2021). Injectable kartogenin and apocynin loaded micelle enhances the alleviation of intervertebral disc degeneration by adipose-derived stem cell. Bioactive Materials. 6(10). 3568–3579. 41 indexed citations

12.

Ying, Liwei, Chenggui Wang, Kesi Shi, et al.. (2021). Interpreting the Mechanisms by which Integrins Promote the Differentiation of Mesenchymal Stem Cells and Integrin Application Prospects. Current Stem Cell Research & Therapy. 16(7). 848–857. 2 indexed citations

13.

Wang, Jingkai, Dongdong Li, Chengzhen Liang, et al.. (2020). Scar Tissue‐Targeting Polymer Micelle for Spinal Cord Injury Treatment. Small. 16(8). e1906415–e1906415. 32 indexed citations

14.

Shu, Jiawei, Feng Cheng, Zhe Gong, et al.. (2020). Transplantation Strategies for Spinal Cord Injury Based on Microenvironment Modulation. Current Stem Cell Research & Therapy. 15(6). 522–530. 11 indexed citations

15.

Huang, Xianpeng, Chenggui Wang, Xiaopeng Zhou, et al.. (2020). Overexpression of the transcription factors OCT4 and KLF4 improves motor function after spinal cord injury. CNS Neuroscience & Therapeutics. 26(9). 940–951. 25 indexed citations

16.

Gong, Zhe, Chenggui Wang, Liwei Ying, et al.. (2020). An injectable recombinant human milk fat globule–epidermal growth factor 8–loaded copolymer system for spinal cord injury reduces inflammation through NF-κB and neuronal cell death. Cytotherapy. 22(4). 193–203. 18 indexed citations

17.

Shu, Jiawei, et al.. (2020). Surgical technique modification of circumferential decompression for thoracic spinal stenosis and clinical outcome. British Journal of Neurosurgery. 37(3). 503–506. 2 indexed citations

18.

Shu, Jiawei, Fangcai Li, Weishan Chen, et al.. (2020). Cervical Flexion Osteotomy through One‐Stage Posterior‐Anterior‐Posterior Approach for Cervical Extension Deformity in Ankylosing Spondylitis: A Novel Surgical Technique. Orthopaedic Surgery. 12(3). 1005–1009. 2 indexed citations

19.

Wang, Chenggui, Zhe Gong, Xianpeng Huang, et al.. (2019). An injectable heparin-Laponite hydrogel bridge FGF4 for spinal cord injury by stabilizing microtubule and improving mitochondrial function. Theranostics. 9(23). 7016–7032. 60 indexed citations

20.

Kuo, Yuh‐Chi, Yun‐Lian Lin, Cheng-Po Huang, Jiawei Shu, & Wei‐Jern Tsai. (2002). A Tumor Cell Growth Inhibitor fromSaposhnikovae divaricata. Cancer Investigation. 20(7-8). 955–964. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact